<scp>KLF</scp> 4 is a key determinant in the development and progression of cerebral cavernous malformations
-
- Roberto Cuttano
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Noemi Rudini
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Luca Bravi
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Monica Corada
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Costanza Giampietro
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Eleanna Papa
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Marco Francesco Morini
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Luigi Maddaluno
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Nicolas Baeyens
- Yale Cardiovascular Research Center New Haven CT USA
-
- Ralf H Adams
- Department of Tissue Morphogenesis Faculty of Medicine Max Planck Institute for Molecular Biomedicine University of Münster Münster Germany
-
- Mukesh K Jain
- Case Cardiovascular Research Institute Cleveland OH USA
-
- Gary K Owens
- Robert M. Berne Cardiovascular Research Center University of Virginia School of Medicine Charlottesville Virginia USA
-
- Martin Schwartz
- Yale Cardiovascular Research Center New Haven CT USA
-
- Maria Grazia Lampugnani
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
-
- Elisabetta Dejana
- IFOM the FIRC Institute of Molecular Oncology Milan Italy
Journal
-
- EMBO Molecular Medicine
-
EMBO Molecular Medicine 8 (1), 6-24, 2015-11-26
Springer Science and Business Media LLC
- Tweet
Details 詳細情報について
-
- CRID
- 1361137043537092736
-
- ISSN
- 17574684
- 17574676
-
- Data Source
-
- Crossref